POCEMON
Point-of-care monitoring and diagnostics for autoimmune diseases
| Coordinatore | PCS PROFESSIONAL CLINICAL SOFTWARE GMBH
Organization address
address: INDUSTRIERING 11 contact info |
| Nazionalità Coordinatore | Austria [AT] |
| Totale costo | 11˙270˙399 € |
| EC contributo | 8˙399˙997 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Funding Scheme | CP |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-01-01 - 2011-06-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
PCS PROFESSIONAL CLINICAL SOFTWARE GMBH
Organization address
address: INDUSTRIERING 11 contact info |
AT (KLAGENFURT) | coordinator | 0.00 |
| 2 |
ABM MERCHANT S.P.A.
Organization address
address: VIA FLEMING 55 contact info |
IT (ROMA) | participant | 0.00 |
| 3 |
ANKO ANONYMOS ETAIREIA ANTIPROSOPEION EMPORIOU KAI VIOMICHANIAS
Organization address
address: ODOS LEOFOROS SYGGROU 44 contact info |
EL (ATHINA) | participant | 0.00 |
| 4 |
ANONYMI ETAIRIA SYSTIMATON ORGANOSIS LEITOURGIAS KAI EPIKOINONIAS EPICHEIRISEON
Organization address
address: SYGGROU 377 contact info |
EL (PALAIOU FALIROU) | participant | 0.00 |
| 5 |
FONDAZIONE BRUNO KESSLER
Organization address
address: VIA SANTA CROCE 77 contact info |
IT (TRENTO) | participant | 0.00 |
| 6 |
GOV3 LIMITED
Organization address
address: VICTORIA STREET 83 contact info |
UK (LONDON) | participant | 0.00 |
| 7 |
IXTENT S.R.O.
Organization address
address: JANKOVCOVA 1569/2C,LIGHTOUSE TOWERS contact info |
CZ (PRAHA 7) | participant | 0.00 |
| 8 |
LANDESKRANKENANSTALTEN-BETRIEBSGESELLSCHAFT
Organization address
address: ST VEITER STRASSE 34 contact info |
AT (KLAGENFURT) | participant | 0.00 |
| 9 |
PANEPISTIMIO IOANNINON
Organization address
address: LEOFOROS STAVROS S NIARCHOS, PANEPISTIMIOUPOLI IOANNINON contact info |
EL (IOANNINA) | participant | 0.00 |
| 10 |
PHARNEXT S.A.S.
Organization address
address: 140 AVENUE DES CHAMPS-ELYSEES contact info |
FR (PARIS) | participant | 0.00 |
| 11 |
RE HAZ SZOLGALTATO KORLATOLT FELELOSSEGU TARSASSAG
Organization address
address: FOGASKEREKU UTCA 4-6 contact info |
HU (BUDAPEST) | participant | 0.00 |
| 12 |
REGIONE LOMBARDIA.
Organization address
address: VIA POLA 14 contact info |
IT (MILANO) | participant | 0.00 |
| 13 |
SESA - COMMERCE HANDELSGMBH
Organization address
address: SCHILLERSTRASSE 87/1/3/6 contact info |
AT (MODLING) | participant | 0.00 |
| 14 |
STOCKHOLMS UNIVERSITET
Organization address
address: UNIVERSITETSVAGEN 10 contact info |
SE (STOCKHOLM) | participant | 0.00 |
| 15 |
TALANTON SA BUSINESS CONSULTING AND MARKETING SERVICES
Organization address
address: PENTELIS 44 contact info |
EL (PALAIO FALIRO) | participant | 0.00 |
| 16 |
THE CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS - THE CYPRUS FOUNDATION FOR MUSCULAR DYSTROPHY RESEARCH
Organization address
address: LEOF AERODROMIOU 6 contact info |
CY (AGIOS DOMETIOS) | participant | 0.00 |
| 17 |
THE ROTHERHAM NHS FOUNDATION TRUST
Organization address
address: MOORGATE ROAD contact info |
UK (ROTHERHAM) | participant | 0.00 |
| 18 |
UNIVERSITA DEGLI STUDI DI MILANO
Organization address
address: Via Festa Del Perdono 7 contact info |
IT (MILANO) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
The POCEMON project aims to the hardware and software development of a multi-purpose autoimmune diseases diagnostic platform by combining Lab-on-Chip (LOC) technologies, genomic micro-arrays of HLA (human leukocyte antigens) typing, microelectronics, mobile devices, intelligent algorithms and wireless communications. The multi-purpose platform will be provided as a portable integrated platform with application to primary care level. The final product will be capable to communicate through its PDA device with the Laboratory Information Server (LIS) for detailed analysis, diagnosis and information extraction concerning autoimmune diseases; the LIS will be also developed inside the time-framework of the project. Microelectronics-micro-fludics for the LOC and robotics for the HLA micro-arrays' construction, constitute the main state-of-the-art scientific technologies which will be employed for the development of the portable diagnostic genomics laboratory.
Autoimmune disorders (diseases) develop when the immune system destroys normal body tissues. HLA genes are the major determinants used by the body's immune system for recognition and differentiation of self from non-self (foreign substances). The combination of LOC technologies with genomic micro-arrays of HLA typing will provide a state-of-the-art diagnosis at primary care level, concerning multiple sclerosis and rheumatoid arthritis which are linked with the HLA CLASS I and II genes.
The development of a primary care diagnostic LOC platform based on micro-arrays of HLA typing is the main target of this proposed project. Easily adapted developments will lead to the diagnosis on the majority of autoimmune disorders. The POCEMON platform will advance and promote primary health care diagnosis across Europe.